• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

白细胞介素6的急性期特性:在川崎病和其他发热性疾病中的研究

The acute phase nature of interleukin 6: studies in Kawasaki disease and other febrile illnesses.

作者信息

Ueno Y, Takano N, Kanegane H, Yokoi T, Yachie A, Miyawaki T, Taniguchi N

机构信息

Department of Pediatrics, School of Medicine, Kanazawa University, Japan.

出版信息

Clin Exp Immunol. 1989 Jun;76(3):337-42.

PMID:2473858
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1541885/
Abstract

Interleukin 6 (IL-6) has manifold biological functions involved in the immune or inflammatory responses of the host to various stimuli. Here we asked whether IL-6 might be responsible for manifestations of Kawasaki disease (KD), such as immunoglobulin hypersecretion, lymphocyte activation and systemic vasculitis. IL-6 activity in the serum was determined by a sensitive colorimetric assay using an IL-6-dependent murine hybridoma clone. Usually sera from healthy or afebrile donors contained only negligible levels of IL-6 activity below the detection threshold of the assay. Importantly it was found that serum IL-6 was markedly elevated in all patients with acute KD. Serum levels of IL-6 activity gradually diminished during the course of the disease and reached undetectable or lower levels at the convalescent phase. However, such elevated levels of serum IL-6 activity were also observed in the majority of other febrile diseases, such as bacterial or viral infections, indicating that the appearance of IL-6 in the serum could generally occur in febrile or inflammatory disease conditions. Serum IL-6 activity correlated with serum concentrations of some acute phase proteins (APP), such as C-reactive protein, haptoglobin and alpha 1-acid glycoprotein, implying its role for modulating induction of APP in vivo. IL-6 is well known to be secreted by a variety of cell types. Further studies, including immunohistochemical analysis using anti-IL-6 antibody, will be necessary to examine whether the source of serum IL-6 in KD might be different from that seen in other diseases.

摘要

白细胞介素6(IL-6)具有多种生物学功能,参与宿主对各种刺激的免疫或炎症反应。在此,我们探讨IL-6是否可能与川崎病(KD)的表现有关,如免疫球蛋白分泌过多、淋巴细胞活化和系统性血管炎。血清中的IL-6活性通过使用依赖IL-6的小鼠杂交瘤克隆的灵敏比色测定法来确定。通常,来自健康或无发热捐赠者的血清中IL-6活性水平极低,低于该测定法的检测阈值。重要的是,发现所有急性KD患者的血清IL-6均显著升高。在疾病过程中,血清IL-6活性水平逐渐降低,在恢复期达到不可检测或更低水平。然而,在大多数其他发热性疾病中,如细菌或病毒感染,也观察到血清IL-6活性水平升高,这表明血清中IL-6的出现通常发生在发热或炎症性疾病状态下。血清IL-6活性与一些急性期蛋白(APP)的血清浓度相关,如C反应蛋白、触珠蛋白和α1-酸性糖蛋白,这意味着其在体内调节APP诱导中的作用。众所周知,IL-6由多种细胞类型分泌。需要进一步的研究,包括使用抗IL-6抗体的免疫组织化学分析,来检查KD患者血清IL-6的来源是否与其他疾病不同。

相似文献

1
The acute phase nature of interleukin 6: studies in Kawasaki disease and other febrile illnesses.白细胞介素6的急性期特性:在川崎病和其他发热性疾病中的研究
Clin Exp Immunol. 1989 Jun;76(3):337-42.
2
[Interleukin 6 activities and tumor necrosis factor-alpha levels in serum of patients with Kawasaki disease].[川崎病患者血清中白细胞介素6活性及肿瘤坏死因子-α水平]
Arerugi. 1991 Feb;40(2):147-54.
3
Serum interleukin-6 in Kawasaki disease.川崎病中的血清白细胞介素-6
Yonsei Med J. 1992 Jun;33(2):183-8. doi: 10.3349/ymj.1992.33.2.183.
4
Circulating adiponectin levels in Kawasaki disease.川崎病患者循环脂联素水平
Acta Paediatr. 2006 Oct;95(10):1312-4. doi: 10.1080/08035250600609799.
5
[Serum interleukin-2 receptor in patients with Kawasaki disease].[川崎病患者血清白细胞介素-2受体]
Arerugi. 1989 Jan;38(1):49-56.
6
Serum soluble E-selectin levels in Kawasaki disease.川崎病患者血清可溶性E选择素水平
Scand J Rheumatol. 1994;23(5):283-6. doi: 10.3109/03009749409103730.
7
Plasma endotoxin and serum cytokine levels in patients with alcoholic hepatitis: relation to severity of liver disturbance.酒精性肝炎患者的血浆内毒素和血清细胞因子水平:与肝脏损害严重程度的关系。
Alcohol Clin Exp Res. 2000 Apr;24(4 Suppl):48S-54S.
8
Serum levels of interleukin-18 are elevated in the subacute phase of kawasaki syndrome.川崎病亚急性期血清白细胞介素-18水平升高。
Int Arch Allergy Immunol. 2004 Oct;135(2):161-5. doi: 10.1159/000080660. Epub 2004 Sep 2.
9
[Value of serum soluble interleukin-2R, interleukin-6 and C-reactive protein in the early diagnosis of Kawasaki disease].[血清可溶性白细胞介素-2受体、白细胞介素-6及C反应蛋白在川崎病早期诊断中的价值]
Zhongguo Dang Dai Er Ke Za Zhi. 2006 Jun;8(3):208-10.
10
Increased serum levels of macrophage migration inhibitory factor in patients with Kawasaki disease.川崎病患者血清巨噬细胞移动抑制因子水平升高。
Scand J Rheumatol. 2007 May-Jun;36(3):222-5. doi: 10.1080/03009740701218790.

引用本文的文献

1
Association of Kawasaki disease with intellectual disability, attention deficit hyperactivity disorder, and autism spectrum disorder: a systematic review and meta-analysis.川崎病与智力残疾、注意力缺陷多动障碍及自闭症谱系障碍的关联:一项系统评价与荟萃分析。
Ital J Pediatr. 2025 Feb 21;51(1):52. doi: 10.1186/s13052-025-01897-w.
2
The Predictive Value of Fibrinogen-to-Albumin Ratio for Predicting Intravenous Immunoglobulin Resistance in Kawasaki Disease: A Prospective Cohort Study.纤维蛋白原与白蛋白比值对预测川崎病静脉注射免疫球蛋白抵抗的价值:一项前瞻性队列研究
Rev Cardiovasc Med. 2024 Nov 22;25(11):421. doi: 10.31083/j.rcm2511421. eCollection 2024 Nov.
3
Platelets in Kawasaki disease: mediators of vascular inflammation.川崎病中的血小板:血管炎症的介质。
Nat Rev Rheumatol. 2024 Aug;20(8):459-472. doi: 10.1038/s41584-024-01119-3. Epub 2024 Jun 17.
4
Prediction of intravenous immunoglobulin retreatment in children with Kawasaki disease using models combining lymphocyte subset and cytokine profile in an East Asian cohort.在一个东亚队列中,使用结合淋巴细胞亚群和细胞因子谱的模型预测川崎病患儿静脉注射免疫球蛋白再治疗情况。
Clin Transl Immunology. 2024 Mar 13;13(3):e1498. doi: 10.1002/cti2.1498. eCollection 2024.
5
Kawasaki Disease and Inborn Errors of Immunity: Exploring the Link and Implications.川崎病与先天性免疫缺陷:探索两者的关联及影响
Diagnostics (Basel). 2023 Jun 23;13(13):2151. doi: 10.3390/diagnostics13132151.
6
Autoptic Findings in Cases of Sudden Death Due to Kawasaki Disease.川崎病所致猝死病例的尸体解剖结果
Diagnostics (Basel). 2023 May 23;13(11):1831. doi: 10.3390/diagnostics13111831.
7
CDCP1 on Dendritic Cells Contributes to the Development of a Model of Kawasaki Disease.树突状细胞上的 CDCP1 有助于川崎病模型的发展。
J Immunol. 2021 Jun 15;206(12):2819-2827. doi: 10.4049/jimmunol.2001406. Epub 2021 Jun 7.
8
Inhibition of IL-6 in the LCWE Mouse Model of Kawasaki Disease Inhibits Acute Phase Reactant Serum Amyloid A but Fails to Attenuate Vasculitis.白介素-6 抑制在川崎病 LCWE 小鼠模型中抑制急性期反应物血清淀粉样蛋白 A,但未能减轻血管炎。
Front Immunol. 2021 Apr 9;12:630196. doi: 10.3389/fimmu.2021.630196. eCollection 2021.
9
Management of COVID-19-associated multisystem inflammatory syndrome in children: A comprehensive literature review.儿童新冠病毒病相关多系统炎症综合征的管理:一项全面的文献综述
Prog Pediatr Cardiol. 2021 Dec;63:101381. doi: 10.1016/j.ppedcard.2021.101381. Epub 2021 Apr 9.
10
KCa3.1 Inhibition of Macrophages Suppresses Inflammatory Response Leading to Endothelial Damage in a Cell Model of Kawasaki Disease.KCa3.1对巨噬细胞的抑制作用可抑制炎症反应,从而在川崎病细胞模型中减轻内皮损伤。
J Inflamm Res. 2021 Mar 5;14:719-735. doi: 10.2147/JIR.S297131. eCollection 2021.

本文引用的文献

1
Human endothelial culture supernatant (HECS): a growth factor for hybridomas.人内皮细胞培养上清液(HECS):一种用于杂交瘤的生长因子。
J Immunol. 1980 Oct;125(4):1411-4.
2
Rapid colorimetric assay for cell viability: application to the quantitation of cytotoxic and growth inhibitory lymphokines.用于细胞活力的快速比色测定法:应用于细胞毒性和生长抑制性淋巴因子的定量分析。
J Immunol Methods. 1984 May 25;70(2):257-68. doi: 10.1016/0022-1759(84)90190-x.
3
No autoantibodies to nuclear antigens in the Kawasaki syndrome.
N Engl J Med. 1983 Apr 28;308(17):1034. doi: 10.1056/NEJM198304283081718.
4
Hepatocyte-stimulating factor: a monocyte-derived acute-phase regulatory protein.肝细胞刺激因子:一种单核细胞衍生的急性期调节蛋白。
Ann N Y Acad Sci. 1983 Jun 27;408:490-502. doi: 10.1111/j.1749-6632.1983.tb23268.x.
5
Immunoregulatory T cell abnormalities in mucocutaneous lymph node syndrome.黏膜皮肤淋巴结综合征中的免疫调节性T细胞异常。
J Immunol. 1983 May;130(5):2002-4.
6
Human keratinocytes and monocytes release factors which regulate the synthesis of major acute phase plasma proteins in hepatic cells from man, rat, and mouse.人类角质形成细胞和单核细胞释放的因子可调节人、大鼠和小鼠肝细胞中主要急性期血浆蛋白的合成。
J Biol Chem. 1984 Jun 10;259(11):7331-42.
7
[Acute febrile mucocutaneous syndrome with lymphoid involvement with specific desquamation of the fingers and toes in children].[儿童急性发热性皮肤黏膜综合征伴淋巴细胞浸润及指(趾)特异性脱屑]
Arerugi. 1967 Mar;16(3):178-222.
8
Induction of a 26-kDa-protein mRNA in human cells treated with an interleukin-1-related, leukocyte-derived factor.用一种白细胞介素-1相关的、白细胞衍生因子处理的人细胞中26-kDa蛋白mRNA的诱导。
Eur J Biochem. 1985 Oct 15;152(2):253-7. doi: 10.1111/j.1432-1033.1985.tb09191.x.
9
Production of hybridoma growth factor by human monocytes.人单核细胞产生杂交瘤生长因子。
Eur J Immunol. 1987 Oct;17(10):1411-6. doi: 10.1002/eji.1830171004.
10
Complementary DNA for a novel human interleukin (BSF-2) that induces B lymphocytes to produce immunoglobulin.一种新型人类白细胞介素(BSF-2)的互补DNA,该白细胞介素可诱导B淋巴细胞产生免疫球蛋白。
Nature. 1986;324(6092):73-6. doi: 10.1038/324073a0.